Updates are available Correction dated 2020-10-28
Click to view Correction: https://doi.org/10.1186/s12964-020-00675-x
-
Authors
Li, Yongxin
Meng, Yu
Zhu, Xiangyang
Saadiq, Ishran M.
Jordan, Kyra L.
Eirin, Alfonso
Lerman, Lilach O. http://orcid.org/0000-0002-3271-3887
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (DK120292, DK122734, DK102325, DK106427, DK122137)
Applied Basic Research Foundation of Yunnan Province (2019A1515010176)
Natural Science Foundation of Guangdong Province (2018A030313527)
- License Information
-
More Information
Article History
Received: 17 April 2020
Accepted: 2 July 2020
First Online: 12 August 2020
Change Date: 28 October 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via the original article.
Ethics approval and consent to participate
: All samples were obtained under a protocol approved by the First Hospital Affiliated to Jinan University Institutional Research Ethics Committee (Guangdong, China). All volunteers provided written informed consent.
: Dr. Lerman receives grant funding from Novo Nordisk, and is an advisor to Weijian Technologies and AstraZeneca. The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
